Endometrial Cancer-current state of the art therapies and unmet clinical needs: The role of surgery and preoperative radiographic assessment

Advanced Drug Delivery Reviews

Volumn 61, Issue 10, 2009, Pages 890-895

  Hunn, Jessica ^a   Dodson, Mark K ^a   Webb, Joel ^a   Soisson, Andrew P ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrial carcinoma; Lymph nodes; Lymphadenectomy

Indexed keywords

ENDOMETRIAL CANCER; ENDOMETRIAL CARCINOMA; LYMPH NODE; LYMPH NODES; LYMPHADENECTOMY; PERITONEAL FLUID; RADIOGRAPHIC ASSESSMENT; STATE OF THE ART; SURGICAL STAGING;

BLOOD VESSELS; DRUG DELIVERY; SURGERY;

BODY FLUIDS;

ABDOMINAL HYSTERECTOMY; CANCER INVASION; CANCER STAGING; CLINICAL EFFECTIVENESS; ENDOMETRIUM CANCER; HUMAN; INTRAOPERATIVE PERIOD; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SENTINEL LYMPH NODE;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING;

EID: 67649233056     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.04.015     Document Type: Review

References (59)

1. Mikuta J.J. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer 71 (1993) 1460-1463
2. Creasman W., Morrow C., Bundy B., et al. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer 60 (1987) 2035-2041
3. Partridge E.E., Jessup J.M., Donaldson E.S., et al. 1996 patient care evaluation study (PCE) of cancer of the corpus uteri. National cancer data-base (NCDB), American College of Surgery. Gynecol. Oncol. 72 (1999) 445
4. Santin A.D., Bellone S., O'Brien T.J., Pecorelli S., Cannon M.J., and Roman J.J. Current treatment options for endometrial cancer. Expert. Rev. Anticancer Th. 4 (2004) 679-689
5. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1999), National Cancer Institute.
6. Kilgore L.C., Partrdige E.E., Alvarez R.D., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56 (1995) 29-33
7. Gershenson D.M. Why American women are not receiving state-of-the-art gynecologic cancer care. Can. J. 6 (2001) 450-457
8. Management of endometrial cancer. ACOG practice bulletin No. 65. American College of Obstetricians and Gynecologists. Obstet. Gynecol. 106 (2005) 413-424
9. Roland A., Kelly F.J., Kulwicki C.Y., et al. Benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol. Oncol. 93 (2004) 125-130
10. Chan J.K., Huahsi W., Cheung M.K., Shin J.Y., Osann K., and Kapp D.S. The outcomes of 27,063 women with unstaged endometriod uterine cancer. Obstet. Gynecol. 106 (2007) 282-288
11. Sorosky J.L. Endometrial cancer. Obstet. Gnecol. 111 (2008) 436-447
12. Cragun J.M., Havrilesky L.J., Calingaert B., Synan I., Secord A.A., Soper J.T., Clarke-Pearson D.L., and Berchuck A. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J. Clin. Oncol. 23 (2005) 3668-3675
13. Chan J.K., Wu H., Cheung M.K., Shin J.Y., Osann K., and Kapp D.S. The outcomes of 27,063 women with unstaged endometrial cancer. Gynecol. Oncol. 106 (2007) 282-288
14. Mariani A., Dowdy S.C., Cliby W.A., Gostout B.S., Jones M.B., Wilson T.O., and Podratz K.C. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol. Oncol. 109 (2008) 11-18
15. Chan J.K., Cheung M.K., Juh W.K., et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107 (2006) 1823-1830
16. Zuurenkonk L.D., Smit R.A., Mol B.W.J., Feijen H.W.H., de Graaff J., Sykora D., de Winter K.A.J., vd Wurff A., Snijders M.P.M.L., and Kruitwagen R.F.P.M. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. J. Cancer Surg. 32 (2006) 450-454
17. Hidaka R., Kato K., Yonezawa R., Shima T., Nakashima A., Nagira K., Nakamura T., and Saito S. Omission of lymphadenectomy is possible for low-risk corpus cancer. J. Cancer Surg. 33 (2006) 86-90
18. Creasman W.T., Odicino F., Maisonneuve P., et al. Carcinoma of the corpus uteri. Int. J. Gynaecol. Obstet. 83 (2003) 79-118 (Suppl)
19. Partridge E.E., Shingleton H.M., and Menck H.R. The National Cancer Data Base report on endometrial cancer. J. Surg. Oncol. 61 (1996) 111-123
20. Barakat R.R., Lev G., Junner A.J., Sonoda Y., Chi D.S., Alektiar K.M., and Abu-Rustum N.R. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol. Oncol. 105 (2007) 150-156
21. Cohn D.E., Huh W.K., Fowler J.M., and Straughn Jr. J.M. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet. Gynecol. 109 (2007) 1388-1395
22. Obermair A., Geramou M., Gucer F., et al. Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilation and curettage compared to the findings at the subsequent hysterectomy. Int. J. Gynecol. Cancer 9 (1999) 383-386
23. Kucera E., Kainz C., Reinthaller A., et al. Accuracy of interaoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecologic Obstetrics Investigation? vol. 49 (2000) 62-66
24. Sant Cassia L.J., Weppelmann B., Shingleton J., Soong S.J., Jatch K., and Salter M.M. Management of early endometrial carcinoma. Gynecol. Oncol. 35 (1989) 362-366
25. Mariani A., Keeney G.L., Aletti G., Webb M.J., Haddock M.G., and Podratz K.C. Endometrial carcinoma: paraaortic dissemination. Gynecol. Oncol. 92 (2004) 833-838
26. Orr Jr. J.W., Orr P.F., and Taylor P.T. Surgical staging endometrial cancer. Clin. Obstet. Gynecol. 39 (1996) 656-668
27. Fanning J., and Firestein S. Prospective trial evaluating morbidity of lymphadenectomy in endometrial cancer. Gynecol. Oncol. 60 (1996) 126
28. Orr Jr. J.W. Surgical management of endometrial cancer: how much is enough?. Gynecol. Oncol. 109 (2008) 1-3
29. Hirahatake K., Jareyama H., Sakuragi N., Nishiya M., Makinoda S., and Fujimoto S. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J. Surg. Oncol. 65 (1997) 82-87
30. Yokoyama Y., Maruyama H., Sato S., and Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol. Oncol. 64 (1997) 411-417
31. Lecuru F., Meji K., Robin F., Darles C., de Bievre P., and Taurelle R. Lymphatic drainage of the uterus: preliminary results of an experimental study [French]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 26 (1997) 418-423
32. Childers J.M., and Surwit E.A. Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer. Gynecol. Oncol. 45 (1992) 486-491
33. Gil-Moreno A., Diaz-Feijoo B., Morchon S., and Xercavins J. Analysis of survival after laparoscopic-assisted vaginal hysterectomy compared with conventional abdominal approach for early-stage endometrial carcinoma: a review of the literature. J. Minim. Invasive Gynecol. 13 (2006) 26-35
34. Barwijuk A., and Jankowska S. Is laparoscopic or abdominal hysterectomy with bilateral salpingo-oophorectomy more efficient in operative treatment of endometrial cancer?. J. Obstet. Gynaecol. 25 (2005) 703-705
35. Cho Y.H., Kim D.Y., Kim J.H., Kim Y.M., Kim Y.T., and Nam J.H. Laparoscopic management of early uterine cancer: 10-year experience in Asan Medical Center. Gynecol. Oncol. 106 (2007) 585-590
36. Frigerio L., Gallo A., Ghezzi F., Trezzi G., Lussana M., and Franchi M. Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in endometrial cancer. Int. J. Gynaecol. Obstet. 93 (2006) 209-213
37. Kim D.Y., Kim M.K., Kim J.H., Suh D.S., Kim Y.M., Kim Y.T., Mok J.E., and Nam J.H. Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in patients with stage I and II endometrial cancer. Int. J. Gynecol. cancer 15 (2005) 932-937
38. Obermair A., Manolitsas R.P., Leung Y., Hammond I.G., and McCartney A.J. Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int. J. Gynecol. cancer 15 (2005) 319-324
39. Obermair A., Manolitsas R.P., Leung Y., Hammond I.G., and McCartney A.J. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol. Oncol. 92 (2004) 789-793
40. Kalogiannidis I., Lambrechts S., Amant F., Neven P., Van Gorp T., and Vergote I. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. Am. J. Obstet. Gynecol. 19 (2007) 248.e1-248.e8
41. Niikura H., Okamura C., Utsunomiya H., Yoshinaga K., Akahira J., Ito K., and Yaegashi N. Sentinel lymph node detection in patients with endometrial cancer. Gynecol. Oncol. 92 (2004) 669-674
42. Ayhan A., Celik H., and Dursun P. Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature. Would J. Surg. Oncol. 6 (2008) 53
43. Burke T.W., LEvenback C., Tornos C., Morris M., Wharton J.T., and Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high risk endometrial cancer: results of a pilot study. Gynecol. Oncol. 62 (1996) 169-173
44. Perrone A.M., Casadio P., Formelli G., Levorato M., Ghi T., Costa S., MEriggiola M.C., and Pelusi G. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol. Oncol. 111 (2008) 62-67
45. Cliby W.A., Clarke-Pearson D.L., Dodge R., Kohler M.F., Rodriguez G., Olt G.J., Soper J.T., Berchuck A., and Soisson A.P. Acute morbidity and mortality associated with pelvic and para-aortic lymphadenectomy in the surgical staging of endometrial adenocarcinoma. J. Gynaecol. Tech. 1 (1995) 19
46. Ruangvutilert P., Sutantawibul A., Sunsaneevithayakul P., Boriboonhirunsarn D., and Chuenchom T. Accuracy of transvaginal ultrasound for the evaluation of myometrial invasion in endometrial carcinoma. J. Med. Assoc. Thail. 87 (2004) 47-52
47. Takac I. Transvaginal ultrasonography with and without saline infusion in assessment of myometrial invasion of endometrial cancer. Ultrasound Med. 26 (2007) 949-7
48. Ortashi O., Jain S., Emannuel O., Henry R., Wood A., and Evans J. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer: a prospective study of 100 cases at the Dorset Cancer Centre. Eur. J. Obstet. Gynecol. Reprod. Biol. 137 (2008) 232-235
49. Vasconcelos C., Felix A., and Cunha T.M. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation. J. Obstet. Gynaecol. 27 (2007) 65-67
50. Cabrita S., Rodrigues H., Abreu R., Martins M., Teixeira L., Marques C., Mota F., and de Oliveira C.F. Magnetic resonance imaging in the preoperative staging of endometrial carcinoma. Eur. J. Gynaecol. Oncol. 29 (2008) 135-137
51. Sanjuan A., Cobo T., Pahisa J., Escaramis G., Ordi J., Ayuso J.R., Garcia S., Hernandez S., Torne A., Martinez Roman S., Lejarcegui J.A., and Vanrell J.A. Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int. J. Gynecol. Cancer 16 (2006) 385-390
52. Torricelli P., Ferraresi S., Fiocchi F., Ligabue G., Jasonni V.M., Di Monte I., and Rivasi F. 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. AJR 190 (2008) 489-495
53. Nakao Y., Yokoyama M., Hara K., Koyamatsu Y., Yasunaga M., Araki Y., Watannabe Y., and Iwasaka T. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol. Oncol. 102 (2006) 343-347
54. Nasi F., Fiocchi F., Pecchi A., Rivasi F., and Torricelli P. MRI evaluation of myometrial invasion by endometrial carcinoma. Comparison between fast-spin-echo T2w and coronal-FMPSPGR Gadolinium-Dota-enhanced sequences. Radiol. Med. 110 (2005) 199-210
55. Rockall A.G., Meroni R., Sohaib S.A., Reynolds K., Alexander-Sefre F., Sheperd J.H., Jacobs I., and Reznek R.H. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int. J. Gynecol. Cancer 17 (2007) 188-196
56. Selman T.J., Mann C.H., Zamora J., and Khan K.S. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health 8 (2008) 8
57. Kitajima K., Murakami K., Yamasaki E., et al. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. Am. J. Roentgenol. 190 (2008) 1652-1658
58. Horowitz N.S., Dehdashti F., Herzog T.J., Powell M.A., Gibb R.K., Grigsby P.W., Siegel B.A., and Mutch D.G. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastases in uterine corpus cancer. Gynecol. Oncol. 95 (2004) 546-551
59. Park J.Y., Kim E.N., Suh D.S., Kim J.H., Kim Y.M., Kim Y.T., and Man J.H. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol. Oncol. 108 (2008) 486-492